Literature DB >> 24382668

MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.

Zhuo-Yuan Lin1, Ya-Qiang Huang, Yan-Qiong Zhang, Zhao-Dong Han, Hui-Chan He, Xiao-Hui Ling, Xin Fu, Qi-Shan Dai, Chao Cai, Jia-Hong Chen, Yu-Xiang Liang, Fu-Neng Jiang, Wei-De Zhong, Fen Wang, Chin-Lee Wu.   

Abstract

Our previous microarray data showed that microRNA-224 (miR-224) was downregulated in human prostate cancer (PCa) tissues compared with adjacent benign tissues. However, the underlying mechanisms by which miR-224 is involved in PCa remain unclear. In this study, we identified TRIB1 as a target gene of miR-224. Forced expression of miR-224 suppressed PCa cell proliferation, invasion and migration, and promoted cell apoptosis by downregulating TRIB1. Moreover, the expression level of miR-224 in PCa tissues was negatively correlated with that of TRIB1. miR-224 downregulation was frequently found in PCa tissues with metastasis, higher PSA level and clinical stage, whereas TRIB1 upregulation was significantly associated with metastasis. Both miR-224 downregulation and TRIB1 upregulation were significantly associated with poor biochemical recurrence-free survival of patients with PCa. In conclusion, these findings reveal that the aberrant expression of miR-224 and TRIB1 may promote PCa progression and have potentials to serve as novel biomarkers for PCa prognosis.
© 2013 UICC.

Entities:  

Keywords:  TRIB1; biochemical recurrence-free survival; clinicopathological feature; microRNA-224; prostate cancer

Mesh:

Substances:

Year:  2014        PMID: 24382668     DOI: 10.1002/ijc.28707

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  51 in total

1.  MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.

Authors:  Hao Fu; Hui-chan He; Zhao-dong Han; Yue-ping Wan; Hong-wei Luo; Ya-qiang Huang; Chao Cai; Yu-xiang Liang; Qi-shan Dai; Fu-neng Jiang; Wei-de Zhong
Journal:  Tumour Biol       Date:  2014-11-15

Review 2.  MicroRNAs in prostate cancer: From function to biomarker discovery.

Authors:  Ahmed A Moustafa; Hogyoung Kim; Rasha S Albeltagy; Ola H El-Habit; Asim B Abdel-Mageed
Journal:  Exp Biol Med (Maywood)       Date:  2018-06

3.  Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.

Authors:  Ute Warnecke-Eberz; Seung-Hun Chon; Arnulf H Hölscher; Uta Drebber; Elfriede Bollschweiler
Journal:  Tumour Biol       Date:  2015-01-29

4.  High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.

Authors:  Jian-Jiang Xie; Yang-Jia Zhuo; Yu Zheng; Ru-Jun Mo; Ze-Zhen Liu; Bo-Wei Li; Zhi-Duan Cai; Xue-Jin Zhu; Yu-Xiang Liang; Hui-Chan He; Wei-de Zhong
Journal:  Int Urol Nephrol       Date:  2017-02-17       Impact factor: 2.370

5.  High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.

Authors:  Shoumin Bai; Ting Chen; Tao Du; Xianju Chen; Yiming Lai; Xiaoming Ma; Wanhua Wu; Chunhao Lin; Leyuan Liu; Hai Huang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

6.  MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.

Authors:  Ri Cui; Wei Meng; Hui-Lung Sun; Taewan Kim; Zhenqing Ye; Matteo Fassan; Young-Jun Jeon; Bin Li; Caterina Vicentini; Yong Peng; Tae Jin Lee; Zhenghua Luo; Lan Liu; Dongyuan Xu; Esmerina Tili; Victor Jin; Justin Middleton; Arnab Chakravarti; Tim Lautenschlaeger; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-17       Impact factor: 11.205

7.  Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN.

Authors:  Ke Hu; Meng Liang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-23       Impact factor: 2.416

Review 8.  Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.

Authors:  Valentina Doldi; Marzia Pennati; Barbara Forte; Paolo Gandellini; Nadia Zaffaroni
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

Review 9.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

10.  Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer.

Authors:  J-G Zhu; D-B Yuan; W-H Chen; Z-D Han; Y-X Liang; G Chen; X Fu; Y-K Liang; G-X Chen; Z-L Sun; Z-Z Liu; J-H Chen; F-N Jiang; W-D Zhong
Journal:  Clin Transl Oncol       Date:  2015-11-13       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.